Last reviewed · How we verify

Phenylephrine HCl Immediate Release

Bayer · Phase 1 active Small molecule

Phenylephrine HCl Immediate Release is a Small molecule drug developed by Bayer. It is currently in Phase 1 development.

At a glance

Generic namePhenylephrine HCl Immediate Release
SponsorBayer
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Phenylephrine HCl Immediate Release

What is Phenylephrine HCl Immediate Release?

Phenylephrine HCl Immediate Release is a Small molecule drug developed by Bayer.

Who makes Phenylephrine HCl Immediate Release?

Phenylephrine HCl Immediate Release is developed by Bayer (see full Bayer pipeline at /company/bayer).

What development phase is Phenylephrine HCl Immediate Release in?

Phenylephrine HCl Immediate Release is in Phase 1.

Related